"Schizophrenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Descriptor ID |
D012559
|
| MeSH Number(s) |
F03.700.750
|
| Concept/Terms |
Schizophrenia- Schizophrenia
- Schizophrenias
- Schizophrenic Disorders
- Disorder, Schizophrenic
- Disorders, Schizophrenic
- Schizophrenic Disorder
- Dementia Praecox
|
Below are MeSH descriptors whose meaning is more general than "Schizophrenia".
Below are MeSH descriptors whose meaning is more specific than "Schizophrenia".
This graph shows the total number of publications written about "Schizophrenia" by people in this website by year, and whether "Schizophrenia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 7 | 1 | 8 |
| 1996 | 16 | 3 | 19 |
| 1997 | 9 | 3 | 12 |
| 1998 | 4 | 0 | 4 |
| 1999 | 4 | 1 | 5 |
| 2000 | 5 | 1 | 6 |
| 2001 | 8 | 3 | 11 |
| 2002 | 5 | 1 | 6 |
| 2003 | 4 | 0 | 4 |
| 2004 | 10 | 1 | 11 |
| 2005 | 7 | 2 | 9 |
| 2006 | 7 | 1 | 8 |
| 2007 | 7 | 4 | 11 |
| 2008 | 13 | 2 | 15 |
| 2009 | 8 | 3 | 11 |
| 2010 | 7 | 2 | 9 |
| 2011 | 12 | 0 | 12 |
| 2012 | 15 | 1 | 16 |
| 2013 | 15 | 1 | 16 |
| 2014 | 17 | 1 | 18 |
| 2015 | 9 | 0 | 9 |
| 2016 | 9 | 2 | 11 |
| 2017 | 12 | 2 | 14 |
| 2018 | 10 | 1 | 11 |
| 2019 | 10 | 4 | 14 |
| 2020 | 12 | 1 | 13 |
| 2021 | 13 | 1 | 14 |
| 2022 | 13 | 0 | 13 |
| 2023 | 10 | 0 | 10 |
| 2024 | 9 | 2 | 11 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Schizophrenia" by people in Profiles.
-
Assessing Trial-by-Trial Electrophysiological and Behavioral Markers of Attentional Control and Sensory Precision in Psychotic and Mood Disorders. Schizophr Bull. 2025 03 14; 51(2):543-555.
-
Characterizing the relationship between personality dimensions and psychosis-specific clinical characteristics. Schizophr Res. 2025 02; 276:88-96.
-
A comprehensive framework for trans-ancestry pathway analysis using GWAS summary data from diverse populations. PLoS Genet. 2024 Oct; 20(10):e1011322.
-
Cross-ancestry analysis of brain QTLs enhances interpretation of schizophrenia genome-wide association studies. Am J Hum Genet. 2024 Nov 07; 111(11):2444-2457.
-
Clinical symptoms and psychosocial functioning in patients with schizophrenia spectrum disorders testing seropositive for anti-NMDAR antibodies: a case-control comparison with patients testing negative. Lancet Psychiatry. 2024 10; 11(10):828-838.
-
Dysfunctional Alpha Modulation as a Mechanism of Working Memory Impairment in Serious Mental Illness. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 Dec; 9(12):1271-1280.
-
Prevalence of prominent and predominant negative symptoms across different criteria for negative symptom severity and minimal positive symptoms: A comparison of different criteria. Schizophr Res. 2024 09; 271:246-252.
-
Gyrification across psychotic disorders: A bipolar-schizophrenia network of intermediate phenotypes study. Schizophr Res. 2024 09; 271:169-178.
-
Network intervention analysis indicates that roluperidone achieves its effect on negative symptoms of schizophrenia by targeting avolition. Eur Neuropsychopharmacol. 2024 Oct; 87:18-23.
-
Characterizing cognitive heterogeneity in first-episode psychosis. Schizophr Res. 2024 05; 267:16-18.